Literature DB >> 11024584

Epidemiologic study of type 2 diabetes in Taiwan.

C Chang1, F Lu, Y C Yang, J S Wu, T J Wu, M S Chen, L M Chuang, T Y Tai.   

Abstract

Diabetes mellitus (DM) in adults is a global health problem, although its prevalence varies widely between different populations and the rate has generally increased worldwide. In Taiwan, the mortality rate from DM has almost doubled over the past 10 years. The prevalence of DM in Taiwan was established between 1985 and 1996 and the rates were between 4.9 and 9.2%. The prevalence of impaired glucose tolerance (IGT) was 15.5% (men 15% and women 15.9%). The prevalence of DM and IGT increased significantly with age for both genders. The significant factors associated with newly diagnosed DM were age, BMI, family history of DM, systolic blood pressure (hypertension), physical activity and serum triglyceride levels. The prevalence of large vessel disease (LVD) in DM and non-diabetic subjects were 20.0 and 12.9%, respectively. Among diabetics, 15.8% had ischemic heart disease (IHD), 1.7% leg vessel disease (leg VD), and 2.5% stroke. In non-diabetics, the prevalence of the aforementioned macroangiopathies were 11.5, 0.2 and 1.2%, respectively. The diabetics had a significantly higher prevalence of macrovascular disease than non-diabetic subjects. The most significantly associated with the LVD was serum cholesterol levels. Serum cholesterol and HbA1(c) were significantly associated with the development of IHD. Cigarette smoking and female gender were significantly associated with the leg VD. The prevalence of diabetic retinopathy (DR) was 35.0%. (background DR 30%, preproliferative DR 2.8% and proliferative DR 2.2%, respectively.) The prevalence of DR for previously and newly diagnosed diabetics were 45.2 and 28.3% (men 42.8 vs. 33.3% and women 47.5 vs. 24.8%), respectively. From multiple logistic regression analysis, duration of DM was the most important risk factor related to DR. Diabetic subjects treated with insulin had a higher risk of developing retinopathy than those treated with dietary control. The prevalence of nephropathy and neuropathy were 12.9 and 23.5%, respectively. For those patients with and those without nephropathy and neuropathy, the duration of DM, percentage of insulin treatment, percentage of hypertension, and fasting plasma glucose were significantly different. Diabetic duration, hypertension, insulin treatment and glycemic control consistently correlated with nephropathy and neuropathy. In conclusion, the prevalence of DM in Taiwan was between 4.9 and 9.2%, and the prevalence of IGT was 15.5%. The possible risk factors of newly diagnosed diabetes were age, family history of DM, BMI, SBP (hypertension), physical activity and triglyceride levels. Diabetes in Chinese subjects share many characteristics similar to other Asian populations. The burden imposed by the chronic complications of diabetes is massive. In Taiwan, the mortality rates from DM have increased greatly over the past 10 years. Reduction of the modificable risk factors such as BMI, hypertenion and dyslipidemia, and increase of physical activity and good glycemic control through public health efforts may help to reduce the risk of DM and its chronic complications.

Entities:  

Mesh:

Year:  2000        PMID: 11024584     DOI: 10.1016/s0168-8227(00)00179-0

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  28 in total

1.  Nocturia indicates a poor health status and increases mortality in male patients with type 2 diabetes mellitus.

Authors:  Hui-Ying Liu; Min-Shen Chung; Hung-Jen Wang; Rue-Tsuan Liu; Yao-Chi Chuang
Journal:  Int Urol Nephrol       Date:  2016-05-07       Impact factor: 2.370

2.  Postmarketing surveillance of acarbose treatment in Taiwanese patients with type 2 diabetes mellitus.

Authors:  Yi-Jen Hung; Shi-Wen Kuo; Chao-Hung Wang; Hung-Yu Chang; Sheng-Hwu Hsieh; Harald Landen
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

3.  Renal impairment is one of appropriate predictors of future diabetic peripheral neuropathy: a hospital-based 6-year follow-up study.

Authors:  Chi-Sheng Wang; Yen-Wei Pai; Ching-Heng Lin; I-Te Lee; Ming-Hong Chang
Journal:  Sci Rep       Date:  2022-03-28       Impact factor: 4.379

4.  Risk factors for nuclear, cortical and posterior subcapsular cataracts in the Chinese population of Singapore: the Tanjong Pagar Survey.

Authors:  P J Foster; T Y Wong; D Machin; G J Johnson; S K L Seah
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

5.  Glucose intolerance in Chinese patients with chronic hepatitis C.

Authors:  Liang-Kung Chen; Shinn-Jang Hwang; Shih-Tzer Tsai; Jiing-Chyuan Luo; Shou-Dong Lee; Full-Young Chang
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

6.  Prevalence of diabetic retinopathy in mainland China: a meta-analysis.

Authors:  Lei Liu; Xiaomei Wu; Limin Liu; Jin Geng; Zhe Yuan; Zhongyan Shan; Lei Chen
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

7.  Risk of esophagus cancer in diabetes mellitus: a population-based case-control study in Taiwan.

Authors:  Kao-Chi Cheng; Yu-Lung Chen; Shih-Wei Lai; Pang-Yao Tsai; Fung-Chang Sung
Journal:  BMC Gastroenterol       Date:  2012-12-12       Impact factor: 3.067

8.  Joint relationship between renal function and proteinuria on mortality of patients with type 2 diabetes: the Taichung Diabetes Study.

Authors:  Cheng-Chieh Lin; Ching-Chu Chen; Pei-Tseng Kung; Chia-Ing Li; Sing-Yu Yang; Chiu-Shong Liu; Wen-Yuan Lin; Cheng-Chun Lee; Tsai-Chung Li; Sharon L R Kardia
Journal:  Cardiovasc Diabetol       Date:  2012-10-19       Impact factor: 9.951

9.  Pregnancy outcomes of anti-hypertensives for women with chronic hypertension: a population-based study.

Authors:  Chen-Yi Su; Herng-Ching Lin; Hsin-Chung Cheng; Amy Ming-Fang Yen; Yi-Hua Chen; Senyeong Kao
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

10.  Population-based cohort analyses of the bidirectional relationship between type 2 diabetes and depression.

Authors:  Pei-Chun Chen; Yen-Ting Chan; Hua-Fen Chen; Ming-Chung Ko; Chung-Yi Li
Journal:  Diabetes Care       Date:  2012-11-12       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.